Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Filings indexed 386 across all filing types
Latest filing 2024-07-11 Regulatory Filings
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2024-07-11 English
Other.pdf
Regulatory Filings
2024-06-11 English
Notice of meeting - English.pdf
Regulatory Filings
2024-06-10 English
Notice of the meeting and record date - English.pdf
Regulatory Filings
2024-05-29 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of Cresco Labs Inc. regarding the interim financial statements and interim MD&A for the period ended March 31, 2024. It is titled 'FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE' and contains no actual financial data or analysis, only a certification statement. The document is short (3012 characters) and primarily serves as an officer attestation. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR).
2024-05-16 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Cresco Labs Inc. It certifies the review and fair presentation of interim financial statements and interim MD&A for the period ended March 31, 2024. The document is primarily an officer certification letter, not containing actual financial data or substantive financial analysis. It references interim filings but does not include them. According to the CERTIFICATION RULE, such certification documents should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (2967 characters), consistent with a certification letter rather than a full report.
2024-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.